48 Week Clinical Study Results in Rosacea Patients
(Department of Dermatology, University of California @ Irvine):
- Significantly Reduced Erythema
(A statistically significant 22% decrease was reported at week 12 and progressed to a 45% decrease by week 36)
- Significantly Reduced Lesions
(A dramatic 21% decrease in papules and pustules was recorded by week 4 with continued improvement to a 89.5% decrease at week 48)
PyratineXR is well tolerated and can be used long term
unlike other treatment modalities.
A Clinical Study for Improving the Appearance of Photodamaged Skin*
(Jerry L. McCullough PhD, Raymond L. Garcia MD, Barry Reece):
- Treatment with Pyratine improved skin roughness by 86%, increased skin moisture content by 41% and reduced fine wrinkles by 22%.
* Journal of Drugs in Dermatology, February 2008, Volume 7, Issue 2
A Clinical Study for Improving the Signs and Symptoms of Rosacea*
(Arisa Ortiz MD, Laila Elkeeb MD, Anne Truitt MD, Rasha Hindiyeh MD, Lisa Aquino MD, Minh Tran, Gerald Weinstein MD):
- Treatment with Pyratine showed a continuous improvement of the skin barrier function as well as a continuous reduction in facial redness, acne lesions and spider veins associated with mild to moderate rosacea.
* Journal of Drugs in Dermatology, May 2009, Volume 8, Issue 5
Download Clinical Study